Pieris Pharmaceuticals
PIRS
#9635
Rank
NZ$36.04 M
Marketcap
$27.30
Share price
-1.88%
Change (1 day)
-4.78%
Change (1 year)

Earnings for Pieris Pharmaceuticals (PIRS)

Earnings in 2024 (TTM): -NZ$25.48 Million

According to Pieris Pharmaceuticals's latest financial reports the company's current earnings are NZ$39.62 Million. In 2022 the company made an earning of -NZ$57.03 Million, an increase over its 2021 earnings that were of -NZ$78.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Pieris Pharmaceuticals from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$25.48 Million
2022 -NZ$57.03 Million-27.24%
2021 -NZ$78.38 Million23.4%
2020 -NZ$63.52 Million45.53%
2019 -NZ$43.65 Million-5.89%
2018 -NZ$46.38 Million63.59%
2017 -NZ$28.35 Million-26.92%
2016 -NZ$38.8 Million63.39%
2015 -NZ$23.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.14 Billion 420.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$9.4 Million-64.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.63 B-10,179.96%๐Ÿ‡บ๐Ÿ‡ธ USA